Advertisement

Topics

Valeant’s site for sore eyes: US FDA again issues CRL

08:02 EDT 8 Aug 2017 | in-PharmaTechnologis

The US FDA has rejected Valeant Pharmaceuticals International’s eye drop candidate following a site inspection at its subsidiary’s facility in Tampa, Florida, US.

Original Article: Valeant’s site for sore eyes: US FDA again issues CRL

NEXT ARTICLE

More From BioPortfolio on "Valeant’s site for sore eyes: US FDA again issues CRL"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...